J. Giordano

发表

Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.

K. Blum, M. Oscar-Berman, Yijun Liu, 2011, Journal of genetic syndromes & gene therapy.

Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence

K. Blum, D. Barh, M. Oscar-Berman, 2013, Journal of addiction research & therapy.

Clinical Practices that can Combat Endemic Legal Opioid Dependence: Genetic Addiction Risk Score (GARS)Ã¢ÂÂ¢, KB220ZÃ¢ÂÂ¢, Comprehensive Analysis of Reported Drugs (CARD) and Electrotherapy

K. Blum, M. Febo, T. Simpatico, 2013 .

Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z

K. Blum, M. Febo, P. Kulkarni, 2017, PloS one.

Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment?

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2012, Molecular Neurobiology.

Sex, Drugs, and Rock ‘N’ Roll: Hypothesizing Common Mesolimbic Activation as a Function of Reward Gene Polymorphisms

K. Blum, M. Oscar-Berman, M. Gold, 2012, Journal of psychoactive drugs.

The Addictive Brain: All Roads Lead to Dopamine

Thomas J. H. Chen, K. Blum, D. Barh, 2012, Journal of psychoactive drugs.

Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE® device therapy: a case series

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Cases journal.

Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2009, Postgraduate medicine.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery

K. Blum, M. Oscar-Berman, R. Badgaiyan, 2015, Journal of reward deficiency syndrome.

Molecular Neurobiology of Addiction Recovery

K. Blum, M. Oscar-Berman, M. Gold, 2013, SpringerBriefs in Neuroscience.

Molecular Neurobiology of Recovery with the Twelve Steps

K. Blum, M. Oscar-Berman, M. Gold, 2013 .

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).

William B. Downs, Margaret A. Madigan, K. Blum, 2013, Journal of behavioral addictions.

Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

Margaret A. Madigan, K. Blum, D. Barh, 2013, Journal of genetic syndromes & gene therapy.

“Dopamine homeostasis” requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America’s drug epidemic

K. Blum, R. Badgaiyan, D. Baron, 2017, Journal of systems and integrative neuroscience.

Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map

William B. Downs, Thomas J. H. Chen, K. Blum, 2011, Journal of psychoactive drugs.

The effects of residential dual diagnosis treatment on alcohol abuse

K. Blum, M. Oscar-Berman, R. Badgaiyan, 2017, Journal of systems and integrative neuroscience.

Genospirituality: Our Beliefs, Our Genomes, and Addictions

William B. Downs, K. Blum, M. Oscar-Berman, 2013, Journal of addiction research & therapy.

Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD).

Margaret A. Madigan, K. Blum, R. Badgaiyan, 2017, Global journal of addiction & rehabilitation medicine.

Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study

William B. Downs, Margaret A. Madigan, Thomas J. H. Chen, 2012, Journal of psychoactive drugs.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

William B. Downs, K. Blum, D. Barh, 2013, Journal of addiction research & therapy.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

William B. Downs, K. Blum, D. Barh, 2012, Journal of addiction research & therapy.

Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech

K. Blum, P. Dumouchel, T. Quatieri, 2013, PloS one.

Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic

Margaret A. Madigan, K. Blum, M. Febo, 2016, Journal of behavioral addictions.

Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce “Dopamine Homeostasis” and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence

K. Blum, M. Febo, Z. Demetrovics, 2016, Clinical medical reviews and case reports.

Coupling Genetic Addiction Risk Score (GARS) and

Margaret A. Madigan, K. Blum, R. Badgaiyan, 2017 .

Neurogenetics and nutrigenomics of reward deficiency syndrome (RDS): Stratification of addiction risk and mesolimbic nutrigenomic manipulation of hypodopaminergic function

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment : Putative Activation of Dopaminergic Pathways in the MesoLimbic Reward Circuitry of Humans

Margaret A. Madigan, K. Blum, D. Barh, 2011 .

Kenneth Blum 1,5,6,8,10,11,12,15*, Marlene Oscar-Berman2, Elizabeth Stuller3, David Miller4,5, John Giordano6, Siobhan Morse6, Lee McCormick7, William Downs B5, Roger L Waite5, Debmalya Barh8, Dennis Neal9, Eric R Braverman1,10, Raquel Lohmann10, Joan Borsten11, Mary Hauser12, David Han13, Yijun Liu

K. Blum, D. Barh, M. Oscar-Berman, 2012 .

Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation.

K. Blum, D. Barh, M. Oscar-Berman, 2012, Journal of genetic syndromes & gene therapy.

Common Phenotype in Patients with Both Food and Substance Dependence: Case Reports.

K. Blum, D. Barh, M. Oscar-Berman, 2013, Journal of genetic syndromes & gene therapy.

Nutrigenomics of Neuradaptogen Amino-Acid-Therapy and Neurometabolic Optimizers: Overcoming carbohydrate bingeing and overeating through neurometabolic mechanisms

Margaret A. Madigan, K. Blum, T. Simpatico, 2011 .

Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report.

Thomas J. H. Chen, K. Blum, D. Barh, 2012, Food & function.

Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study.

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2013, Journal of addiction research & therapy.

Hypothesizing that Putative Dopaminergic, Melatonin, Benzodiazepine Reward Circuitry Receptor(s) Activator Provides Sleep Induction Benefits

Margaret A. Madigan, K. Blum, T. Simpatico, 2014 .

Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2013 .

Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence Behaviors

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

GENETIC ADDICTION RISK SCORE (GARS) ANALYSIS: EXPLORATORY DEVELOPMENT OF POLYMORPHIC RISK ALLELES IN POLY-DRUG ADDICTED MALES

Margaret A. Madigan, K. Blum, M. Kerner, 2010 .

UNDERSTANDING THE HIGH MIND: HUMANS ARE STILL EVOLVING GENETICALLY

William B. Downs, Margaret A. Madigan, K. Blum, 2011 .

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration.

K. Blum, R. Badgaiyan, D. Baron, 2020, Journal of systems and integrative neuroscience.

Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2 Agonist Therapy: Part 2

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Postgraduate medicine.

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

Thomas J. H. Chen, K. Blum, M. Oscar-Berman, 2011, Molecular Neurobiology.

Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Current neuropharmacology.

Genetic Addiction Risk Score (GARS): Testing For Polygenetic Predisposition and Risk to Reward Deficiency Syndrome (RDS)

K. Blum, F. Fornari, E. Braverman, 2011 .

Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms.

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2012, Journal of genetic syndromes & gene therapy.

Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.

K. Blum, M. Oscar-Berman, T. Simpatico, 2012, Journal of genetic syndromes & gene therapy.

NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2015, Journal of reward deficiency syndrome.

Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: “Born Bad”

D. Mash, K. Blum, P. Thanos, 2017, Journal of reward deficiency syndrome and addiction science.

Dopamine Genetics and Function in Food and Substance Abuse.

K. Blum, D. Barh, M. Oscar-Berman, 2013, Journal of genetic syndromes & gene therapy.

NEUROGENETIC IMPAIRMENTS OF BRAIN REWARD CIRCUITRY LINKS TO REWARD DEFICIENCY SYNDROME (RDS) AS EVIDENCED BY GENETIC ADDICTION RISK SCORE (GARS): A CASE STUDY

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Translational Research to Uncover Diagnostic & Therapeutic Gene Targets Emerging in a Genomic Era: from Bench to Bedside

K. Blum, T. Simpatico, E. Braverman, 2012 .

Disorders & Genetic Reports

K. Blum, T. Simpatico, J. Giordano, 2012 .

Hypothesizing Synergy between Acupuncture/ Auriculotherapy and Natural Activation of Mesolimbic Dopaminergic Pathways: Putative Natural Treatment Modalities for the Reduction of Drug Hunger and Relapse

Margaret A. Madigan, K. Blum, D. Barh, 2011 .

Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).

Margaret A. Madigan, Kenneth Blum, Thomas J. H. Chen, 2010, Medical hypotheses.

Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.

K. Blum, M. Febo, M. Gold, 2013, Medical hypotheses.

Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors

K. Blum, R. Badgaiyan, D. Baron, 2022, International journal of environmental research and public health.

Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech

K. Blum, D. Barh, P. Dumouchel, 2013, PLoS ONE.

Drug Abuse Relapse Rates Linked to Level of Education: Can We Repair Hypodopaminergic-Induced Cognitive Decline With Nutrient Therapy?

Margaret A. Madigan, K. Blum, M. Oscar-Berman, 2014, The Physician and sportsmedicine.

Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS)

R. Badgaiyan, D. Baron, T. McLaughlin, 2020, Journal of systems and integrative neuroscience.

Understanding the Importance of Dopaminergic Deficit in Reward Deficiency Syndrome (RDS): Redeeming Joy Overcoming "Darkness" in Recovery

K. Blum, M. Febo, R. Badgaiyan, 2015 .

Audio Therapy Significantly Attenuates Aberrant Mood in Residential Patient Addiction Treatment: Putative Activation of Dopaminergic Pathways in the Meso-Limbic Reward Circuitry of Humans

Margaret A. Madigan, K. Blum, D. Barh, 2013 .

Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia

Kenneth Blum, Uma Damle, Thomas J. H. Chen, 2010, Neuropsychiatric disease and treatment.

Critical Analysis of White House Anti-Drug Plan

Margaret A. Madigan, K. Blum, R. Badgaiyan, 2017, Global journal of addiction & rehabilitation medicine.

Neuropsychiatric Genetics of Happiness, Friendships and Politics: A New Era in Understanding Social Interface

K. Blum, T. Simpatico, E. Braverman, 2012 .

R. Badgaiyan, D. Baron, T. McLaughlin, 2020, Journal of systems and integrative neuroscience.

Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors.

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis

P. Thanos, R. Badgaiyan, D. Baron, 2023, Medical research archives.

Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2010, Medical hypotheses.

Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)

Margaret A. Madigan, Thomas J. H. Chen, K. Blum, 2009, Postgraduate medicine.

Generational Association Studies of Dopaminergic Genes in Reward Deficiency Syndrome (RDS) Subjects: Selecting Appropriate Phenotypes for Reward Dependence Behaviors

Margaret A. Madigan, Thomas J. H. Chen, D. Comings, 2011, International journal of environmental research and public health.

The effects of residential dual diagnosis treatment on alcohol abuse

K. Blum, M. Oscar-Berman, R. Badgaiyan, 2017, Journal of systems and integrative neuroscience.

Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.

K. Blum, M. Oscar-Berman, M. Gold, 2013 .

Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.

M. Oscar-Berman, John A. Bailey, Anthony M Gonzalez, 2011, Journal of genetic syndrome & gene therapy.

Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development

Margaret A. Madigan, P. Thanos, R. Badgaiyan, 2024, INNOSC theranostics & pharmacological sciences.

The Marc Pro TM Device Improves Muscle Performance and Recovery from Concentric and Eccentric Exercise Induced Muscle Fatigue in Humans: A Pilot Study

K. Blum, L. Kravitz, J. Baker, 2011 .

Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography

P. Thanos, R. Badgaiyan, T. McLaughlin, 2024, Journal of addiction psychiatry.